Pradaxa litigation
Litigation alleged that the blood thinner Pradaxa caused severe and sometimes fatal bleeding during the years it was sold without any reversal agent.
Free case review
What the litigation alleged
Pradaxa (dabigatran) was marketed as a convenient replacement for warfarin, but until 2015 there was no antidote to stop a serious bleed. The litigation alleged the manufacturer overstated the drug’s safety and understated the importance of monitoring.
Injuries named in the litigation
- Gastrointestinal hemorrhage
- Intracranial bleeding
- Fatal bleeding events
Who may qualify
If you or a family member suffered a major bleeding event while taking Pradaxa, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.